Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$798M |
| 2 |
AT&T
T
|
+$527M |
| 3 |
Microchip Technology
MCHP
|
+$472M |
| 4 |
Netflix
NFLX
|
+$446M |
| 5 |
PNC Financial Services
PNC
|
+$444M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$694M |
| 2 |
KeyCorp
KEY
|
+$401M |
| 3 |
Deere & Co
DE
|
+$322M |
| 4 |
CSX Corp
CSX
|
+$318M |
| 5 |
NXP Semiconductors
NXPI
|
+$314M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.93% |
| 2 | Technology | 4.66% |
| 3 | Healthcare | 4.45% |
| 4 | Industrials | 4.14% |
| 5 | Consumer Discretionary | 3.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6276
PUT
CVR Energy
CVI
$3.54B
| $587K | ﹤0.01% |
14,600
-41,500
| -74% | -$1.56M |
|
6277
CALL
Clearway Energy Class C
CWEN
$7.01B
| $587K | ﹤0.01% |
30,500
-375,000
| -92% | -$7.15M |
|
|
MPT
6278
PUT
Medical Properties Trust
MPT
$2.5B
| $587K | ﹤0.01% |
39,400
+2,100
| +6% | +$30.6K |
|
6279
Stepan Co
SCL
$1.48B
| $587K | ﹤0.01% |
6,749
-4,178
| -38% | -$360K |
|
6280
First Trust Nasdaq Bank ETF
FTXO
$322M
| $586K | ﹤0.01% |
21,000
-17,649
| -46% | -$518K |
|
6281
CALL
Iovance Biotherapeutics
IOVA
$3.16B
| $586K | ﹤0.01% |
52,100
+24,100
| +86% | +$342K |
|
6282
Uranium Energy
UEC
$5.55B
| $586K | ﹤0.01% |
340,635
+217,743
| +177% | +$362K |
|
|
YELL
6283
CALL
DELISTED
Yellow Corporation Common Stock
YELL
| $586K | ﹤0.01% |
65,300
+42,000
| +180% | +$407K |
|
6284
CALL
Ares Management
ARES
$32.5B
| $585K | ﹤0.01% |
25,200
+14,900
| +145% | +$320K |
|
6285
iShares MSCI Indonesia ETF
EIDO
$489M
| $585K | ﹤0.01% |
+25,460
| New | +$592K |
|
|
TRK
6286
DELISTED
Speedway Motorsports, Inc.
TRK
| $585K | ﹤0.01% |
32,765
+917
| +3% | +$16.2K |
|
|
CNR
6287
CALL
Core Natural Resources Inc
CNR
$4.76B
| $584K | ﹤0.01% |
14,300
+6,800
| +91% | +$286K |
|
6288
PUT
Funko
FNKO
$344M
| $583K | ﹤0.01% |
+24,600
| New | +$494K |
|
6289
PUT
Innospec
IOSP
$2.31B
| $583K | ﹤0.01% |
7,600
| – | – |
|
|
ODP
6290
CALL
DELISTED
ODP
ODP
| $583K | ﹤0.01% |
18,150
+5,110
| +39% | +$153K |
|
|
PR
6291
PUT
Permian Resources
PR
$18B
| $583K | ﹤0.01% |
26,700
+16,300
| +157% | +$307K |
|
6292
PUT
AptarGroup
ATR
$8.4B
| $582K | ﹤0.01% |
5,400
+1,500
| +38% | +$154K |
|
6293
Goldman Sachs BDC
GSBD
$1.11B
| $582K | ﹤0.01% |
26,249
-25,558
| -49% | -$560K |
|
|
AVEO
6294
CALL
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $582K | ﹤0.01% |
17,580
+6,370
| +57% | +$164K |
|
6295
CALL
Delek Logistics
DKL
$2.87B
| $581K | ﹤0.01% |
17,100
-600
| -3% | -$18.5K |
|
6296
CALL
Enovis
ENOV
$1.5B
| $581K | ﹤0.01% |
+9,354
| New | +$533K |
|
6297
Fresenius Medical Care
FMS
$12.7B
| $581K | ﹤0.01% |
11,297
+1,903
| +20% | +$95.2K |
|
6298
CALL
LivePerson
LPSN
$35.2M
| $581K | ﹤0.01% |
1,493
+333
| +29% | +$123K |
|
|
IMGN
6299
PUT
DELISTED
Immunogen Inc
IMGN
| $580K | ﹤0.01% |
61,200
+3,000
| +5% | +$28.8K |
|
6300
iShares MSCI Belgium ETF
EWK
$162M
| $579K | ﹤0.01% |
+30,202
| New | +$600K |
|
Similar funds
Citadel Advisors's Q3 2018 Portfolio in Review
As of Q3 2018, Citadel Advisors held 10,190 positions worth $224B, up 10% from $203B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citadel Advisors deployed $7.48B of net new capital in Q3 2018, opening 1,427 new positions and adding to 4,227 existing holdings. Its largest new stake was Alibaba: 1,030,311 shares worth $170M.
By sector, the portfolio is most concentrated in Financials at 5.9% of assets, down from 6.2% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Goldman Sachs, an estimated $694M trimmed.
- Citadel Advisors's largest Q3 2018 buy was Alibaba: 1,030,311 shares worth $170M.
- Citadel Advisors added most to Morgan Stanley in Q3 2018, an estimated $798M increase.
- Citadel Advisors's biggest Q3 2018 reduction was Goldman Sachs, cutting an estimated $694M.
- Citadel Advisors fully exited XL Group Ltd. in Q3 2018, selling an estimated $207M.
- Citadel Advisors's ten largest holdings make up 25% of its $224B portfolio in Q3 2018.
- Citadel Advisors opened 1,427 new positions and closed 1,043 in Q3 2018.
- Citadel Advisors's portfolio value rose 10% quarter-over-quarter to $224B.
Based on Citadel Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.